MedTrace Logo

Methylprednisolone Addition in IVF Treatment of Infertile Couples

NCT01220791 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2010-10-14

No results posted yet for this study

Summary

Hypothesis to be tested is whether follicular addition of Methylprednisolone can efficiently control late follicular progesterone rise during IVF treatment

Conditions

  • In Vitro Fertilization

Interventions

OTHER

In vitro fertilization treatment for infertility

IVF treatment

Sponsors & Collaborators

  • BioGenesis

    collaborator INDUSTRY

  • HRG

    collaborator UNKNOWN

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Basil Tarlatzis, Professor · BioGenesis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
36 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-12-31
Completion
2011-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01220791 on ClinicalTrials.gov